ACTRN12618001318279招募中4 期
Intra-operative intravenous tranexamic acid during laparoscopic surgery for severe endometriosis - a double-blinded randomized placebo controlled trial
The Royal Women's Hospital0 个研究点目标入组 200 人开始时间: 2018年8月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Suspected severe endometriosis (based on clinical or radiological evidence or findings at previous diagnostic laparoscopy)
- •Proposed laparoscopic surgery to treat endometriosis of > 2 hours
- •Planned surgery under level 6 gynaecological surgeons’ operating lists
排除标准
- •Non consent
- •Non English speaking
- •Allergy or contraindication to tranexamic acid including: thrombophilia, previous/active thromboembolic disease, subarachnoid haemorrhage, malignancy or antithrombotic treatment
- •Hysterectomy planned as part of procedure
- •Other bleeding disorder
研究者
相似试验
进行中（未招募）
1 期
Peroperative Administration of Tranexamic acid in gastric bypass to reduce haemorrhage in patients with morbid obesityMorbid obesityMedDRA version: 21.1Level: LLTClassification code: 10068900Term: Bariatric surgery Class: 10042613MedDRA version: 21.0Level: LLTClassification code: 10027966Term: Morbid obesity Class: 10027433MedDRA version: 21.1Level: LLTClassification code: 10059610Term: Obesity surgery Class: 10042613CTIS2024-513570-22-00Sint Franciscus Vlietland Groep Stichting1,524
招募中
3 期
Peroperative Administration of Tranexamic acid in Roux-en-Y and one-anastomosis gastric bypass to reduce hemorrhage rates (PATRY study): a randomized controlled trialNL-OMON53532Franciscus Ziekenhuis1,524
已完成
3 期
Peroperative Administration of Tranexamic Acid in Sleeve gastrectomy (PATAS) to reduce hemorrhage ratesNL-OMON47960Sint Franciscus Gasthuis112
已完成
不适用
Peroperative administration of tranexamic acid in sleeve gastrectomyMorbid obesityNL-OMON28904one100
招募中
1 期
Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trialMelanomaSurgeryCTIS2022-502633-26-00Aarhus University Hospital1,204